Valuation — not yet established
No valuation for Nervmyo Therapeutics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Nervmyo Therapeutics with a free account
- ·Watch Nervmyo Therapeutics: the Monday email on marks, rounds and moves
Nervmyo Therapeutics funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2025 | Accelerator/Incubator | — | ▮ | ▮ |
Unlock post-money valuations
Membership and data by Private Market View
How Nervmyo Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Nervmyo Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Nervmyo Therapeutics
- When did Nervmyo Therapeutics last raise?
- Nervmyo Therapeutics last raised in Aug 2025 (Accelerator/Incubator).